Wuhan Keqian Biology Co.,Ltd (SHA:688526)

China · Delayed Price · Currency is CNY

11.72

+0.02 (0.17%)

Nov 6, 2026, 11:14 AM CST

Market Cap	5.44B -26.6%
Revenue (ttm)	786.77M -22.4%
Net Income	226.99M -50.6%
EPS	0.49 -50.4%
Shares Out	463.92M
PE Ratio	24.10
Forward PE	11.14
Dividend	0.64 (5.46%)
Ex-Dividend Date	May 26, 2026

Volume	809,112
Open	11.52
Previous Close	11.70
Day's Range	11.47 - 11.80
52-Week Range	11.11 - 17.81
Beta	0.40
Analysts	Strong Buy
Price Target	17.50 (+49.32%)
Earnings Date	Oct 31, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Employees 935

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688526

Full Company Profile

Financial Performance

In 2025, SHA:688526's revenue was 949.74 million, an increase of 0.83% compared to the previous year's 941.92 million. Earnings were 418.72 million, an increase of 9.51%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 688526 stock is "Strong Buy." The 12-month stock price target is ¥17.50, which is an increase of 49.32% from the latest price.

Price Target

¥17.50

(49.32% upside)

Analyst Consensus: Strong Buy

Stock Forecasts